cs-206
Cell therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 2, 2024 (NCT06565026)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Stem CellSupplementation
Stem Cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07000318 | Early Phase 1 (Phase 1) | Jun 30, 2025 | Fudan University |
| NCT06565026 | Early Phase 1 (Phase 1) | Sep 2, 2024 | Government of China, Hacettepe University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Fudan University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Government of China | Government | 1 | 1 | 1 | 2024 |
| Hacettepe University | Academic/Hospital | 1 | 0 | 1 | 2024 |
3 organizations
Page 1 / 1